A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study).
about
The emerging role of immunotherapy in colorectal cancerPhase 1 study of OCV-C02, a peptide vaccine consisting of two peptide epitopes for refractory metastatic colorectal cancer.An evaluation of the anti-angiogenic effect of the Korean medicinal formula "Sa-mi-yeon-geon-tang" in vitro and in ovo.Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model.Prediction of the efficacy of immunotherapy by measuring the integrity of cell-free DNA in plasma in colorectal cancer.Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study.Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer.MicroRNA-6826 and -6875 in plasma are valuable non‑invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer.Cetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancerNovel avenues in immunotherapies for colorectal cancer.miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancerModulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model.Characterization of the T cell repertoire by deep T cell receptor sequencing in tissues and blood from patients with advanced colorectal cancer.miR-125b-1 and miR-378a are predictive biomarkers for the efficacy of vaccine treatment against colorectal cancer.Immunotherapy regimens for metastatic colorectal carcinomas.Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens.Updates on immunotherapy for colorectal cancer.Immunotherapy in colorectal cancer: for the select few or all?Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy.Novel targeting approaches and signaling pathways of colorectal cancer: An insight
P2860
Q28067898-250BC9D2-F52C-4B21-BB6C-983ABC1990CFQ33738883-20F9E011-A637-4057-866C-088E3BE9E8CAQ35177173-97DEE04B-DEAF-478D-B14F-DE758C5406C5Q36198223-07244055-089D-4193-9B37-DAD3F718CB65Q37544605-D9C402D6-AD2A-4FE6-ABA5-CDC195AE184EQ37566054-9F9DB68E-5B09-4DD6-9DD5-64BCCA512F38Q37611667-079C39A0-597C-4995-9675-CF776BEDC2FAQ37671162-D77A04B3-7CFA-43AE-B3CB-6776C587B76FQ37707611-43D46C85-97C9-4730-B94A-CF6124044C2FQ37735615-4CCFD78A-848B-4FDC-BB8F-C3F93220042EQ38637906-0352CD27-FD2E-44DC-80A1-67970F37CEF9Q41143092-CB3EAC14-75EF-4562-BBDB-8168D86896B0Q41595487-83F81868-5E59-42FD-9B70-8BC1569494E8Q41822936-2F68506C-7857-48CF-986F-D4C77F0412C3Q46803210-9D61F8E5-4908-44F4-A4F6-3AFF137F08A3Q48103017-C1C28847-B635-4E66-A6AD-30AB0C0B550DQ49483662-BA448694-2A3B-4FEA-A48E-E309B651E70EQ52643529-51E5E436-4508-4577-AD45-77C5F64D1F21Q55333223-F931462A-5BF1-48BF-820C-7DE90D373C78Q55715408-16354838-9D46-4157-AE67-D51B6624C584Q57807128-6C163B6B-AD5E-4316-A64C-445B4B4A7544
P2860
A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study).
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A phase ΙI study of five pepti ...... colorectal cancer (FXV study).
@ast
A phase ΙI study of five pepti ...... colorectal cancer (FXV study).
@en
type
label
A phase ΙI study of five pepti ...... colorectal cancer (FXV study).
@ast
A phase ΙI study of five pepti ...... colorectal cancer (FXV study).
@en
prefLabel
A phase ΙI study of five pepti ...... colorectal cancer (FXV study).
@ast
A phase ΙI study of five pepti ...... colorectal cancer (FXV study).
@en
P2093
P2860
P356
P1476
A phase ΙI study of five pepti ...... colorectal cancer (FXV study).
@en
P2093
Akira Kamiya
Fumiaki Sugiura
Hiroaki Ozasa
Hiroaki Tanaka
Hirokazu Shinozaki
Hiroko Takenouchi
Hiroyuki Furukawa
Kazuhiko Yoshimatsu
Kiyotaka Okuno
P2860
P2888
P356
10.1186/1479-5876-12-108
P577
2014-04-30T00:00:00Z
P5875
P6179
1019251108